Psychiatric Times Vol 35, Issue 5

May 08, 2018

With greater expertise in user experiences, psychiatrists can position themselves to more strongly guide technology companies in building and implementing better apps.

May 14, 2018

Why aren’t we Americans as happy as we should be, given all the wonderful things we have in our lives?

May 07, 2018

DSM focuses on the difference between Bipolar I and II. But there’s another way to categorize the illness that may have more relevance to treatment.

May 15, 2018

I wanted this to be like a fairy tale walk in the woods before kids, careers, blood clots and bone mets...

May 16, 2018

It is time for the psychiatric and wider medical world to embrace lessons from the growing science of resilience to treat the wide range of stress-related medical and psychiatric disorders more effectively.

May 18, 2018

The US is facing the largest epidemic of opioid overdose deaths in its history. This CME addresses issues associated with the medication-assisted treatment protocol for opioid use disorder.

May 23, 2018

Why do positive emotional feelings make us feel more connected to others?

May 24, 2018

Psychogenic purpura is a rare and poorly understood syndrome. However, early recognition and intervention can lead to remissions which may last years.

May 25, 2018

Four psychiatrists have joined the distinguished members of our Editorial Board. And our Editorial Director passes the torch.

May 29, 2018

To understand the experiences and needs of the aging LGBTQ population, it is important to consider the culture, politics, and social norms that existed when these elders came of age. Clinicians can play a vital role by creating a safe and open environment that allows people to be themselves.

May 31, 2018

The impetus to consider inflammation as potentially relevant to the pathoetiology of domain-based psychopathology (eg, anhedonia) and/or mental disorders, is provided by a confluence of factors discussed here.

May 31, 2018

The studies reviewed in this article provide a new model for clinical practice-one where the treatment of depressed patients is not governed by trial and error, but rather where patients can access new interventions sooner.

May 30, 2018

A drug once seen as a widespread danger to society is now experiencing renewed interest as a treatment for medical conditions, including a number of mental health conditions. This brief review explores 5 key issues clinicians can consider when encountering the therapeutic cannabis user.